Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
MedBright AI Appoints Trevor Vieweg as Chief Executive Officer
-
Quanta Announces IND Clearance by U.S. FDA for QTX3034, G12D-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates
-
CytomX Therapeutics Outlines 2024 Company Priorities and Milestones
-
Simbe Announces 3X Year-Over-Year Growth and Path to Profitability
-
DIRTT and SourceBlue Announce Strategic Alliance to Transform the Interior Construction Procurement Process
-
authID Continues Growth Momentum with Strong Q4 Sales
-
Reviva Provides Corporate and Program Updates and Highlights Key Upcoming Milestones
-
Portillo’s Inc. to Participate in the 2024 ICR Conference
-
Viracta Therapeutics Provides Clinical Update and Outlook for 2024
-
Bion’s Ammonia Recovery Technology Optimization Moves to Final Design
-
Madrigal Pharmaceuticals Presents Five Health Economics Outcomes Research Abstracts at the NASH-TAG Annual Conference
-
OncoC4 to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fi
-
Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC)
-
IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
-
Speeding in neighbourhoods a major concern, Canadians say
-
Northern Technologies International Corporation to Announce Fiscal 2024 First Quarter Financial Results and Host Conference Call
-
Claris Bio Emerges From Stealth With a New Investor and Prepares for Next Development Stage With Late-Stage Data Expected in 1H24
-
XWELL Announces Plans to Open an XpresSpa in THE PENN DISTRICT
-
BOS to Release 2023 Fourth Quarter and Year End Financial Results and Host a Conference Call on March 28, 2024
-
Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases
-
Sacks Parente Golf Appoints Golf Industry Veteran Jane Casanta as Newest Board Member
-
Vislink Appoints Christopher DeSalvo as Chief Financial Officer and Vice President of Operations
-
Sigyn Therapeutics Releases Letter to Shareholders
-
Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products
-
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
-
Scott Macklin Joins Obra Capital as Head of US Leveraged Finance
-
Genasys to Present at Leading Investor Conferences
-
Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation
-
iCoreConnect Inc. Announces Strategic Acquisition of Teamworx Dental
-
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
-
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial Cancer
-
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
-
Kratos and Rancher Government Solutions Announce Strategic Partnership to Enable Customers to Seamlessly Deploy and Scale Virtual Ground Systems Using Kratos’ OpenSpace® Software Platform
-
Assembly Biosciences Provides Anticipated Development Milestones for 2024
-
European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology
-
Lisata Therapeutics Announces Publication of Case Report on a Complete Response in a Metastatic Gastroesophageal Adenocarcinoma Patient Treated with LSTA1 in Combination with Standard-of-Care Therapy
-
Bion’s Ammonia Recovery Technology Optimization Moves to Final Design
-
NewAmsterdam Pharma Announces 2024 Strategic Priorities
-
The Government of Ecuador Approves Atico’s Concession Extension Until 2049
-
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing
-
ZeroFox Awarded $289M from U.S. Office of Personnel Management for Digital Identity Protection Services
-
authID Continues Growth Momentum with Strong Q4 Sales
-
Super League to Host Virtual Non-Deal Roadshow Webinar on Wednesday, January 17, 2024, at 11:00 a.m. Eastern Time
-
Casa Systems Appoints Former Google Executive Santanu Dasgupta as Chief Technology Officer
-
Constellium to Showcase Cutting-Edge Solutions for Aluminium Automotive Structures at CES 2024 in Las Vegas
-
Well+Good Launches Well/Mess: A New Approach to January Wellness
-
Ocuphire Pharma Receives FDA Agreement Under Special Protocol Assessment for LYNX-2 Phase 3 Trial of Phentolamine Ophthalmic Solution for the Treatment of Decreased Visual Acuity under Dim (mesopic) L
-
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
